Cerephex to seek FDA clearance for fibromyalgia treatment

06/3/2010 | Medical Devices Today

Cerephex said it will submit an application with the FDA within a year to seek 510(k) clearance for NeuroPoint, a non-invasive device that delivers cortical stimulation to treat fibromyalgia. The company plans to schedule a July meeting with the agency to ask for comments on its two-year study data.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY